Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06141109
Status:
RECRUITING
Last Update Posted:
2023-11-21
First Post:
2023-11-09
Brief Title:
Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma
Sponsor:
Xian Xintong Pharmaceutical Research CoLtd
Organization:
Xian Xintong Pharmaceutical Research CoLtd
Organization Data
Organization:
Xian Xintong Pharmaceutical Research CoLtd
Class:
OTHER
Study ID:
H201110LC3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xian Xintong Pharmaceutical Research CoLtd
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The First Hospital of Jilin University | OTHER |